Since the discovery of IDO1 in 1967, the development of IDO1 inhibitors has been mainly focused on the treatment of neurological disorders and neurodegenerative diseases (Cady and Sono, 1991; Ma et al., 1999). The gene discussed is IDO1; the disease is nervous system disorder.